| RE50497 |
(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide |
Brandon Heath Brown, Ernest A. Carra, Jeffrey N. Hemenway, Troy Reynolds, Bing Shi +5 more |
2025-07-22 |
| 12351588 |
Salt forms and solvates of Mcl-1 antagonists |
Jason Tedrow, Stephan D. Parent, Courtney S. Johnson, Travis L. Houston, Melanie Janelle Bevill |
2025-07-08 |
| 12221417 |
Salt of omecamtiv mecarbil and process for preparing salt |
Sheng Cui, Karthik Nagapudi, Shawn D. WALKER, Charles Bernard, Karl Hansen +4 more |
2025-02-11 |
| 12122781 |
Hydrates of polymorphs of 6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-a]pyrazin-8-amine bis-mesylate as Syk inhibitors |
Tim G. Elford, Peter Fung, Paul Robert Hartmeier, Jesper Alexis Jernelius |
2024-10-22 |
| 11958809 |
Salt of omecamtiv mecarbil and process for preparing salt |
Sheng Cui, Karthik Nagapudi, Shawn D. WALKER, Charles Bernard, Karl Hansen +6 more |
2024-04-16 |
| 11926592 |
Salts and crystal forms of omecamtiv mecarbil |
Sheng Cui, Kyle Quasdorf, Evelyn Yanez, Bin Peter Quan, Ron C. Kelly +5 more |
2024-03-12 |
| RE49445 |
N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide |
Brandon Heath Brown, Ernest A. Carra, Jeffrey N. Hemenway, Troy Reynolds, Bing Shi +5 more |
2023-03-07 |
| 11583531 |
Solid forms of a toll-like receptor modulator |
Sylvie M. Asselin, Pavel R. Badalov, Christopher S. Regens, Tiago Vieira |
2023-02-21 |
| 11472773 |
Salt of omecamtiv mecarbil and process for preparing salt |
Sheng Cui, Karthik Nagapudi, Shawn D. WALKER, Charles Bernard, Karl Hansen +6 more |
2022-10-18 |
| 11465969 |
Salts and crystal forms of omecamtiv mecarbil |
Sheng Cui, Kyle Quasdorf, Evelyn Yanez, Bin Peter Quan, Ron C. Kelly +9 more |
2022-10-11 |
| 11396509 |
Solid forms of a toll-like receptor modulator |
Sylvie M. Asselin |
2022-07-26 |
| 11384082 |
Hydrates of polymorphs of 6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-A]pyrazin-8-amine bisemsylate as Syk inhibitors |
Tim G. Elford, Peter Fung, Paul Robert Hartmeier, Jesper Alexis Jernelius |
2022-07-12 |
| RE48285 |
N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide |
Brandon Heath Brown, Ernest A. Carra, Jeffrey N. Hemenway, Troy Reynolds, Bing Shi +5 more |
2020-10-27 |
| 10183951 |
Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof |
John Amedio, Sijun Hu |
2019-01-22 |
| 9988354 |
Salt of omecamtiv mecarbil and process for preparing salt |
Sheng Cui, Karthik Nagapudi, Shawn D. WALKER, Charles Bernard, Karl Hansen +4 more |
2018-06-05 |
| 9862728 |
Crystalline forms of an antiviral compound |
Dustin Bringley, Johann Chan, Peter Fung, Katie Ann Keaton, Olga Viktorovna Lapina +1 more |
2018-01-09 |
| 9809559 |
(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide |
Brandon Heath Brown, Ernest A. Carra, Jeffrey N. Hemenway, Troy Reynolds, Bing Shi +5 more |
2017-11-07 |
| 9562058 |
Crystalline forms of an antiviral compound |
Dustin Bringley, Johann Chan, Peter Fung, Katie Ann Keaton, Olga Viktorovna Lapina +1 more |
2017-02-07 |
| 9469613 |
(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide |
Brandon Heath Brown, Ernest A. Carra, Jeffrey N. Hemenway, Troy Reynolds, Bing Shi +5 more |
2016-10-18 |
| 8357798 |
Process for preparing N-alkylated hydroxypyrimidinone compounds |
Kevin M. Belyk, Philip Jones, Vincenzo Summa, V. Brett Cooper, Amar J. Mahajan +7 more |
2013-01-22 |
| 7754731 |
Potassium salt of an HIV integrase inhibitor |
Kevin M. Belyk, Amar J. Mahajan, Daniel J. Kumke, Hsien-Hsin Tung, Lawrence Wai +1 more |
2010-07-13 |
| 7144915 |
Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) |
Stephen R. Byrn, David Coates, Karen S. Gushurst, Joseph Francis Krzyzaniak, Zheng Li +2 more |
2006-12-05 |
| 6605729 |
Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-&bgr;,&dgr;-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) |
Stephen R. Byrn, David Coates, Karen S. Gushurst, Joseph Francis Krzyzaniak, Zheng Li +2 more |
2003-08-12 |
